New data reveals that combining pertuzumab with trastuzumab significantly improves survival rates in HER2+ breast cancer patients, reducing death risk by 17%.
Patients with diabetes using glucagon-like peptide-1 (GLP-1) drugs face double the risk of developing neovascular age-related macular degeneration, highlighting crucial ocular health concerns.
Shawn Kwatra, MD and Carolyn Stolte, CRNP discuss how, primary care providers can effectively diagnose, assess, and manage atopic dermatitis by recognizing diverse clinical presentations, utilizing…
Article with CBER leader proposes road map to examine foods and pharmaceuticals to make America healthy again.
The FDA approves clesrovimab-cfor, a new RSV vaccine, offering infants effective protection against severe respiratory illness during their first RSV season.
An existing infrastructure of teleconsulting as part of a Web-based platform was key to creating a national, real-time teleconsulting program for helping primary care providers…
Mukkamala, a Flint-based otolaryngologist recovering from brain cancer, pledges to address physician burnout, workforce shortages and access to care.
Innovative pain management strategies emerge as experts advocate for personalized, multifaceted approaches to chronic pain, likening treatment to a tailored cupcake.
This cross-sectional study investigates when the recent declines in US drug overdose death rates began and whether rate changes differed by census region, drug type,…
A new study reveals the combination therapy enhances safety and efficacy for high-risk BRAF-mutated stage II melanoma.
How much respect do hospitalists feel they receive in their day-to-day jobs? Read analysis of four statements asked in annual survey.
